9 completed, 1 unknown, 1 withdrawn. 5 Phase 2, 3 Phase 3, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Allerderm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metal Panel Allergen Patch Test Study Metal Panel T.R.U.E. Test - Atopic Dermatitis Eczema | Phase 3 | Unknown | Allerderm | 200 | 2022-02-07 | 2023-02-13 |
| Clinical Evaluation of Metal Panel Allergens: Dose Response Study Metal Allergen Epicutaneous Patch - Dermatitis, Eczematous | Phase 2 | Completed | Allerderm | 122 | 2016-12-05 | 2020-08-25 |
| Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study Ammoniated mercury, Aluminum chloride and aluminum lactate, Sodium tetrachloropalladate - Contact Dermatitis | Phase 2 | Completed | Allerderm | 56 | 2013-11-04 | 2020-08-24 |
| Clinical Evaluation of Lyral® Dose Response Study Lyral® - Contact Dermatitis | Phase 2 | Completed | Allerderm | 22 | 2013-02-01 | 2023-07-28 |
| Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Panels 1.3, 2.2 and 3.2 experimental allergens - Allergic Contact Dermatitis | Not applicable | Completed | Allerderm | 116 | 2012-12-10 | 2020-08-21 |
| Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents Patch Test - Contact Dermatitis | Phase 3 | Withdrawn | Allerderm | 2012-12-01 | 2013-02-27 | |
| Bioequivalence of Ethylenediamine Dihydrochloride Study Ethylenediamine dihydrochloride allergen patch - Allergic Contact Dermatitis | Phase 4 | Completed | Allerderm | 16 | 2012-07-01 | 2023-07-28 |
| Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents T.R.U.E. Test - Dermatitis, Contact | Phase 4 | Completed | Allerderm | 102 | 2008-11-01 | 2020-08-06 |
| Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens - Contact Dermatitis | Phase 2 | Completed | Allerderm | 48 | 2008-04-01 | 2018-04-09 |
| Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens - Contact Dermatitis | Phase 3 | Completed | Allerderm | 235 | 2008-04-01 | 2020-05-05 |
| Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations TRUE Test allergens Fragrance Mix and Thimerosol - Dermatitis, Contact | Phase 2 | Completed | Allerderm | 50 | 2008-01-01 | 2018-04-09 |
Dermatitis, Contact (8) · Dermatitis, Allergic Contact (3) · Eczema (2) · Dermatitis (1) · Hypersensitivity (1)
Patch Tests (1) · Thimerosal (1) · hydroxyisohexyl 3-cyclohexene carboxaldehyde (1)
United States (9) · Denmark (3) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Sweden (1) · Switzerland (1)
Joseph Fowler, MD (6) · Cory Dunnick, MD (2) · Evy Paulsen, M.D., Ph.D (2) · Jerri Hoskyn, MD (2) · Lawrence Eichenfield, MD (2) · Luz Fonacier, MD (2) · Akiko Yagami, MD, PhD (1) · Andreas Bircher, MD (1) · Curt Hamann, M.D. (1) · Donald V Belsito, MD (1) · Donald V. Belsito, MD (1) · Evy Paulsen, Md, PhD (1) · Karin Pacheco, MD (1) · Maki Hosoki, DDS, PhD (1) · Marlene Isaksson, MD (1)
2008 (1)